跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
DESFAX desvenlafaxine 50mg modified release tablets blister
Approved
STANDARD
DESFAX desvenlafaxine 50mg modified release tablets blister
Medis Pharma Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
b6041b6440fae3d8
Company
Medis Pharma Pty Ltd
Type
Standard
Approval Details
Approval Id
b6041b6440fae3d8
Product Name
DESFAX desvenlafaxine 50mg modified release tablets blister
Artg Id
218075
Artg Name
DESFAX desvenlafaxine 50mg modified release tablets blister
Sponsor
Medis Pharma Pty Ltd
Company Detail Path
/organization/medis-pharma-pty-ltd
Artg Date
2014-11-26
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/6b1426caec5da3b2b59ae0e65fc0d1d4.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/74cf835555268d468234caae871bbf9e.pdf
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
b6041b6440fae3d8
Type
Standard
Back to TGA Approvals
DESFAX desvenlafaxine 50mg modified release tablets blister - TGA Drug Approval Details